Jefferies Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $31
Novavax Analyst Ratings
Jefferies Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $31
Jefferies Sticks to Their Buy Rating for Novavax (NVAX)
B.Riley Financial Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $23
B.Riley Financial Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $23
Buy Rating Affirmed for Novavax Amid Strong Vaccine Candidate Performance and Competitive Edge
Novavax (NVAX) Gets a Sell From J.P. Morgan
J.P. Morgan Maintains Novavax(NVAX.US) With Sell Rating, Raises Target Price to $9
Novavax Price Target Cut to $23.00/Share From $25.00 by B. Riley Securities
Novavax Analyst Ratings
JP Morgan Maintains Underweight on Novavax, Raises Price Target to $9
B. Riley Adjusts Price Target on Novavax to $23 From $25, Maintains Buy Rating
Analysts Offer Insights on Healthcare Companies: Novavax (NVAX), Regulus (RGLS) and Canopy Growth (CGC)
Novavax Poised for U.S. Market Capture and Cost Efficiency Gains: A Resounding Buy Rating
Novavax (NVAX) Receives a Hold From Bank of America Securities
Novavax: Strategic Shifts and Cost-Cutting Amidst Market Uncertainty Prompt Hold Rating
Novavax Price Target Cut to $25.00/Share From $29.00 by B. Riley Securities
Novavax Analyst Ratings
B.Riley Financial Maintains Novavax(NVAX.US) With Buy Rating, Cuts Target Price to $25